The report focuses on the investment landscape in women's health, highlighting the disparity between the proportion of funding allocated to women's health (6%) versus the population it represents (nearly 50%).
It discusses the investment gap, market maturity, access issues, and areas ripe for investment in women's health. Key findings include the macroeconomic benefits of investing in women's health, growing investor momentum, and specific investment opportunities such as cancer therapeutics, virtual healthcare, and wearable metabolic health devices.